• Search
  • Helpdesk
  • Sales contact
Get your demo
☰

Put an end to eCOA misconceptions #infography

4 July 2020

Discover below the 5 reasons to adopt eCOA solutions.
Want to learn more about eCOA misconceptions? Click here!

5 reasons to adopt eCOA solutions

To download “Put an end to eCOA misconceptions”:

[tag url=”https://kayentis.com/wp-content/uploads/2020/05/put-an-end-to-ecoa-misconceptions.pdf”]

Learn more:

Follow us on social media
Subscribe to our newsletter
You may also like

Kayentis 2024 Gender Equality Index

Kayentis enlists experts in oncology, neurodegenerative and metabolic disorders to...

The unquestionable value of electronic Clinical Outcome Assessments (eCOA) in...

Breaking barriers in pediatric clinical trials: perspectives from two expert...

Ensure successful outcomes with strong patient collaboration at every stage...

Empowering healing: The impact of patient partnerships in clinical trials

About the author
Picture of Marc Chaperon

Marc Chaperon

Estelle brings 20+ years of experience in pre-clinical and clinical research from Top 5 Pharma and Biotech firms. Leading projects across Phases 1 to 4 in diverse therapeutic areas, she offers deep insights into clinical science, operations, and regulatory intricacies. Appointed as Chief Medical Officer at Kayentis in May 2019.
Meet us at the following events

C-PATH 2025

APR 9-10 2025 • Rockville, Maryland, USA

OCT Europe 2025

APR 29-30 2025 • Barcelona, Spain
Booth #74 15th Annual Outsourcing in Clinical Trials Europe 2025 - Arena International

OCT East Coast 2025

MAY 20-21 2025 • King of Prussia, USA
Booth #44 16th Annual Outsourcing in Clinical Trials East Coast 2025 - Arena International

PCMG 2025

JUNE 10-12 2025 • Malaga, Spain
PCMG Annual Assembly 2025

Kayentis Europe
19 bis, chemin du vieux Chêne
38240 Meylan
France
Phone: +33 (0)4 76 00 54 20

Kayentis US
186 South Street
Suite 600
Boston, Massachusetts 02111
USA